This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Birdie Biopharmaceuticals, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Walter Lau - Innovator in Targeted Immunotherapy
Introduction
Walter Lau is a prominent inventor based in Beijing, China. He has made significant contributions to the field of immunotherapy, particularly in the treatment of tumors and cancers. His innovative work focuses on developing targeted therapies that can improve patient outcomes.
Latest Patents
Walter Lau holds a patent for "Anti PD-L1 conjugates for treating tumors." This invention discloses anti-PD-L/PD-1 Axis antibody conjugates designed for targeted immunotherapy. The patent also includes compositions comprising these conjugates and outlines their use in the treatment of tumors and cancers.
Career Highlights
Walter Lau is associated with Birdie Biopharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective cancer treatments.
Collaborations
Walter collaborates with Lixin Li, contributing to the innovative environment at Birdie Biopharmaceuticals, Inc. Their combined expertise enhances the potential for groundbreaking discoveries in the field of biopharmaceuticals.
Conclusion
Walter Lau's contributions to targeted immunotherapy exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in cancer treatment, showcasing the importance of research and collaboration in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile